

Editorially independent content supported with advertising by Allergan (an AbbVie company), Glaukos, and New World Medical.
Choosing an Approach Amid Postoperative Concerns
I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD
In the first episode of the Interventional Glaucoma Case Series, I. Paul Singh, MD; Nathan Radcliffe, MD; and Sarah Van Tassel, MD, dissect a case involving the use of the iStent Inject (Glaukos) in a patient with a history of selective laser trabeculoplasty, cataracts, fluctuating IOPs, poor medication adherence, and significant concerns about postoperative visual recovery. The experts also describe scenarios in which the use of the newer iStent Inject W (Glaukos) may be preferred.
Other Videos
Editorially independent content supported with advertising by Allergan (an AbbVie company), Glaukos, and New World Medical.
